Design, synthesis and bioactive evaluation of novel quinoline-linked sulfonamide-pyridine derivatives as PI3K/HDAC dual-target inhibitors.

In the treatment of malignant tumors, dual-target inhibitors can effectively avoid the compensatory activation of other signaling pathways caused by single-target administration, as well as the pharmacokinetic changes and poor patient compliance asso…

Preview only. Read the full abstract at the source